Characterization of the DWNN domain and ring finger-like motif within the DCM of the Drosophila melanogaster SNAMA protein
No Thumbnail Available
Date
2009-05-25T13:03:09Z
Authors
Antunes, Ricardo Jorge
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
SNAMA is a 139 kDa Drosophila melanogaster protein belonging to the
Retinoblastoma Binding Protein 6 (RbBP6) superfamily. Mammalian
RbBP6 interacts with both p53 and Rb and plays a critical role in
embryonic development and tumorigenesis as a negative regulator of p53.
All RbBP6 members contain a 5´ DWNN Catalytic Domain (DCM)
consisting of a DWNN (domain with no name) domain followed by a zinc
finger and RING (really interesting new gene) finger motif. RING finger
and U-box ubiquitin ligases are dependent on their RING finger
conformation for their ubiquitin ligase activity. The main focus of this work
was to further elucidate the functional characteristics of the DCM within
SNAMA. This was achieved by examinining transcription regulation of the
SNAMA gene and determining whether SNAMA exhibits ubiquitin ligase
activity. 5´ Rapid amplification of cDNA ends (RACE) was used to
determine the core promoter elements of SNAMA through the discovery of
the transcription initiation site. Ubiquitin conjugation assays using pure
recombinant SNAMA as the ubiquitin ligase were performed to analyze the
ubiquitin ligase activity of the protein. Transcriptional regulation of the
SNAMA gene is achieved through a single TATA-less promoter that gives
rise to a single transcript of 3.9 kb. Furthermore, this work shows that
SNAMA is a unique RING finger ubiquitin ligase that is capable of autoubiquitination
in the absence of zinc ions. This activity is dependent on its
RING finger-like motif, which has greatest specificity to the UbcH5a
conjugating enzyme. Furthermore, SNAMA relies on E1, E2, ATP, and
ubiquitin for its E3 activity. Thus, SNAMA is the first member of the
RbBP6 family to portray RING finger ubiquitin ligase activity and
represents a “drugable” target for pharmaceutical intervention.